Bozeman, MT (April 22, 2014) — Today Golden Helix announced the availability of Version 2 of its free genome browser for viewing sequence data. The Golden Helix GenomeBrowse® visualization tool was released in September 2012 and since then has garnered over 2,500 registrations.
Stated Dr. Andreas Scherer, President and CEO of Golden Helix, “GenomeBrowse was created to help researchers in our field to navigate very large datasets. It provides an intuitive way to review genomic information. From the very start GenomeBrowse was meant to be a free product. This is Golden Helix’s way to give back to the genetics community and increase our profile amongst researchers. The tool is used by researchers worldwide as they discover root causes for diseases and traits. Just recently, it was cited in a Nature Genetics letter.”1
Version Two of the tool includes several features requested by the GenomeBrowse community including:
The ability to add custom genome reference sequences through a Data Conversion Wizard.
Native, first-class integration with Evernote, a free app for organizing and collaborating notes across a variety of devices and people.
The option to access sample files over a network (FTP or HTTP) and/or the cloud.
Built-in automation functionality to control GenomeBrowse programmatically via HTTP remote access.
Support for additional file formats including BED and WIG.
“The addition of the conversion wizard, Evernote integration, and network options truly makes GenomeBrowse first-class. No other genome browser on the market can compare to GenomeBrowse’s ease-of-use and product quality,” said Gabe Rudy, Vice President of Product Development.
The availability of GenomeBrowse Version 2 follows the release of Version 8 of Golden Helix’s flagship product, SNP & Variation Suite (SVS), last month.
Golden Helix has been delivering industry leading bioinformatics solutions for the advancement of life science research and translational medicine for over 15 years. Our innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from microarrays and next-generation sequencing. With our solutions, hundreds of the world’s top pharmaceutical, biotech, and academic research organizations are able to harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine. Golden Helix products and services have been cited in over 800 peer-reviewed publications.